Investigating the Presence of Haemophilus Influenzae in Patients with Chronic Obstructive Pulmonary Disease (COPD) Using Molecular Method

Document Type : Original Article (s)

Authors

1 Department of Cellular and Molecular Biology, School of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

2 Assistant Professor, Craniomaxillofacial Research Center AND Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 Assistant Professor, Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD) AND Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a type of obstructive pulmonary disease characterized by chronic airway blockage. The aim of this study was to investigate the presence of Haemophilus influenzae in patients with COPD using molecular method.Methods: A total of 100 samples of respiratory secretion were collected from patients with COPD. The molecular identification of Haemophilus influenza was performed using specific primers against standard kits by polymerase chain reaction (PCR) method.Findings: Haemophilus influenzae bacteria were positive in 10 out of 100 patients, and 8 of 100 were positive in PCR using specific primers.Conclusion: Nucleic acid-like PCR tests, due to their sensitivity, high accuracy, and time saving, are the appropriate method for diagnosis of Haemophilus influenzae in patients with chronic pulmonary obstruction.

Keywords

References

  1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370(9589): 741-50.
  2. Devereux G. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ 2006; 332(7550): 1142-4.
  3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6): 932-46.
  4. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the lung health study. Am J Respir Crit Care Med 2001; 164(3): 358-64.
  5. Ghoshal AG, Dhar R, Kundu S. Treatment of acute exacerbation of COPD. J Assoc Physicians India 2012; 60 Suppl: 38-43.
  6. Martinez FJ. Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4(8): 647-58.
  7. Hausner M, Schamberger A, Naumann W, Jacobs E, Dumke R. Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan. Microb Pathog 2013; 64: 23-32.
  8. Maaroufi Y, De Bruyne JM, Heymans C, Crokaert F. Real-time PCR for determining capsular serotypes of Haemophilus influenzae. J Clin Microbiol 2007; 45(7): 2305-8.
  9. Saadati M, Nazarian S, Barati B, Mehdizadeh H, Shirzad H S, Sadeghizadeh M, et al. simultaneous molecular detection of Neisseria meningitidis and Haemophilus influenzae. Modares J Med Sci Pathol 2008; 11(1-2): 73-80. [In Persian].
  10. Shimizu K, Yoshii Y, Morozumi M, Chiba N, Ubukata K, Uruga H, et al. Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods. Int J Chron Obstruct Pulmon Dis 2015; 10: 2009-16.
  11. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: Using smoking rates to estimate disease frequency in the general population. Chest 2000; 117(5 Suppl 2): 354S-9S.
  12. Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, Garcia-Nunez M, et al. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012; 9(2): 121-30.
  13. Desai H, Eschberger K, Wrona C, Grove L, Agrawal A, Grant B, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2014; 11(3): 303-9.
  14. Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Duval V, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: A pilot prospective study. J Med Virol 2013; 85(5): 866-73.
  15. Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, et al. Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology 2011; 157(Pt 8): 2181-95.
  16. Honda J, Yano T, Kusaba M, Yonemitsu J, Kitajima H, Masuoka M, et al. Clinical use of capillary PCR to diagnose Mycoplasma pneumonia. J Clin Microbiol 2000; 38(4): 1382-4.
  17. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1992; 340(8833): 1432-4.
Journal of Isfahan Medical School
Volume 37, Issue 527 - Serial Number 527
March and April 2019
Pages 517-521

Files

History

  • Receive Date: 24 May 2019
  • Revise Date: 26 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics